Iconic Labs PLC Conversion of Notes and Allotment of Shares
07 Febrero 2024 - 3:10AM
RNS Regulatory News
RNS Number : 3265C
Iconic Labs PLC
07 February 2024
7 February
2024
Iconic Labs
PLC
("Iconic"
or the "Company")
Conversion of Notes and
Allotment of Shares
Iconic Labs PLC (LSE:ICON)
announces that it has received a valid Conversion Notice from
the European High Growth Opportunities Securitization Fund
("EHGO").
The Conversion Notice was
dated 6 February 2024 and provides for 20 Convertible Notes to
be converted into 200,000 ordinary shares of £0.1 in the
Company ("Ordinary Shares") at a conversion price
of £0.1 at the aggregate principal amount
of £20,000.
The Conversion Notice also included
a Conversion Fee, payable under the financing arrangements with
EHGO, in the event that the price at 90% of the Lowest Closing
Volume-Weighted Average Price during the applicable pricing period
falls below the nominal value of the Ordinary Shares. The
Conversion Fee has been satisfied by the issue to EHGO of an
additional 654,700 Ordinary Shares.
Application is therefore being made
for an aggregate of 854,700 new Ordinary Shares to be admitted to
trading on the Main Market of the London Stock
Exchange which is expected to be on or around 12 February
2024. These shares rank pari passu with the existing Ordinary
Shares of the Company.
Following the issue of these shares,
the Company's issued ordinary share capital shall consist
of 11,161,483 Ordinary Shares. The figure of 11,161,483
represents the total voting rights in the Company and should be
used by shareholders as the denominator for the calculation by
which they can determine if they are required to notify their
interest in, or a change to their interest in, the Company under
the Financial Conduct Authority's Disclosure Guidance &
Transparency Rules.
This announcement contains inside
information for the purposes of Article 7 of the Market Abuse
Regulation (EU) 596/2014 as it forms part of UK domestic
law by virtue of the European Union (Withdrawal) Act 2018
("MAR"), and is disclosed in accordance with the Company's
obligations under Article 17 of MAR.
For
any further information or enquiries please
contact:
ir@iconiclabs.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCUPURUPUPCUBM
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Iconic Labs (LSE:ICON)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
